Sales 2024 * | 2.72B 10.12B 227B | Sales 2025 * | 3.05B 11.35B 255B | Capitalization | 14.3B 53.17B 1,194B |
---|---|---|---|---|---|
Net income 2024 * | 439M 1.63B 36.64B | Net income 2025 * | 528M 1.96B 44.07B | EV / Sales 2024 * | 4.77 x |
Net cash position 2024 * | 1.32B 4.89B 110B | Net cash position 2025 * | 2.15B 8B 180B | EV / Sales 2025 * | 3.98 x |
P/E ratio 2024 * |
34.6
x | P/E ratio 2025 * |
28.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.08% |
Latest transcript on NICE Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Barak Eilam
CEO | Chief Executive Officer | 49 | 30/14/30 |
Darren Rushworth
PSD | President | 56 | 01/17/01 |
Mary Gaspich
DFI | Director of Finance/CFO | 59 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Léo Apotheker
BRD | Director/Board Member | 69 | 01/13/01 |
David Kostman
CHM | Chairman | 59 | 01/01/01 |
Dan Falk
BRD | Director/Board Member | 79 | 01/01/01 |
1st Jan change | Capi. | |
---|---|---|
+10.26% | 3,082B | |
+8.06% | 84.92B | |
+4.54% | 78.23B | |
-14.19% | 54.06B | |
-23.48% | 46.79B | |
+21.61% | 45.87B | |
+22.01% | 42.68B | |
+57.48% | 37.28B | |
-10.15% | 24.89B |